{"id":"terlipressin-and-noradrenaline","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypertension"},{"rate":"null","effect":"Tachycardia"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2135460","moleculeType":"Protein","molecularWeight":"1227.40"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Terlipressin works by stimulating the V1A receptors on vascular smooth muscle cells, causing vasoconstriction and increased blood pressure. Noradrenaline also acts on the alpha-adrenergic receptors, causing vasoconstriction and increased blood pressure. This combination of drugs is used to treat severe hypotension and shock.","oneSentence":"Terlipressin is a vasopressin analogue that acts as a vasoconstrictor, while noradrenaline is a catecholamine that acts as a vasoconstrictor and increases blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:04.761Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe hypotension and shock"}]},"trialDetails":[{"nctId":"NCT07178366","phase":"NA","title":"Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-05-10","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":56},{"nctId":"NCT07131306","phase":"PHASE2","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2027-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07075315","phase":"PHASE3","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2028-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT05346393","phase":"NA","title":"HRS-AKI Treatment With TIPS in Patients With Cirrhosis","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2022-11-29","conditions":"Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury","enrollment":124},{"nctId":"NCT06556472","phase":"NA","title":"Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-08-15","conditions":"Acute on Chronic Liver Failure","enrollment":126},{"nctId":"NCT05774067","phase":"NA","title":"Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-01","conditions":"Norepinephrine, Glypressin, Tourniquet Deflation, Hypotension","enrollment":135},{"nctId":"NCT03822091","phase":"PHASE3","title":"Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-01-28","conditions":"Type 1 HEPATO RENAL SYNDROME(HRS)","enrollment":60},{"nctId":"NCT05207280","phase":"PHASE3","title":"Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic Shock","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-10-11","conditions":"Septic Shock","enrollment":152},{"nctId":"NCT04339868","phase":"PHASE2","title":"Terlipressin for Refractory Septic Shock","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2020-04-03","conditions":"Septic Shock, Refractory Shock, Norepinephrine Adverse Reaction","enrollment":130},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":"Hypotension","enrollment":22435},{"nctId":"NCT03336814","phase":"PHASE4","title":"Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-07-27","conditions":"Septic Shock","enrollment":40},{"nctId":"NCT02573727","phase":"NA","title":"To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-10","conditions":"Acute on Chronic Liver Failure","enrollment":120},{"nctId":"NCT02468063","phase":"NA","title":"To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-05-01","conditions":"Cirrhosis With Septic Shock","enrollment":184},{"nctId":"NCT01836224","phase":"NA","title":"Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-10","conditions":"Cirrhosis With Septic Shock","enrollment":84},{"nctId":"NCT01649037","phase":"NA","title":"To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome","status":"WITHDRAWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2012-08","conditions":"Hepatorenal Syndrome","enrollment":""},{"nctId":"NCT00628160","phase":"PHASE2, PHASE3","title":"Terlipressin in Septic Shock in Cirrhosis","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2006-10","conditions":"Liver Cirrhosis, Septic Shock","enrollment":72},{"nctId":"NCT02306239","phase":"NA","title":"The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients","status":"UNKNOWN","sponsor":"Liu ZiMeng","startDate":"2014-12","conditions":"Terlipressin, Septic Shock","enrollment":40},{"nctId":"NCT01697410","phase":"NA","title":"Continuos Terlipressin Infusion in Septic Shock","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2013-01","conditions":"Septic Shock","enrollment":1000},{"nctId":"NCT01271114","phase":"PHASE3","title":"Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension","status":"TERMINATED","sponsor":"Hospital General de Ciudad Real","startDate":"2012-06","conditions":"Septic Shock, Sepsis-associated Hypotension","enrollment":21},{"nctId":"NCT01637454","phase":"PHASE3","title":"TYPE 2 HEPATORENAL SYNDROME","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2009-01","conditions":"Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS","enrollment":46},{"nctId":"NCT00995839","phase":"PHASE2, PHASE3","title":"Terlipressin in Septic Shock: Effects on Microcirculation","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2008-11","conditions":"Septic Shock, Sepsis","enrollment":60},{"nctId":"NCT00481572","phase":"PHASE2","title":"Continuous Infusion of Terlipressin in Septic Shock","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2007-01","conditions":"Septic Shock","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Terlipressin and Noradrenaline","genericName":"Terlipressin and Noradrenaline","companyName":"Post Graduate Institute of Medical Education and Research, Chandigarh","companyId":"post-graduate-institute-of-medical-education-and-research-chandigarh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Terlipressin is a vasopressin analogue that acts as a vasoconstrictor, while noradrenaline is a catecholamine that acts as a vasoconstrictor and increases blood pressure. Used for Severe hypotension and shock.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}